Brainsway Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 11, 2026, by Brainsway Ltd., a foreign private issuer based in Jerusalem, Israel, incorporates by reference the company's Fourth Quarter and Full Year 2025 financial results and operational highlights. The filing serves as a notification of material events for the month of March 2026.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced Exhibit 99.1 ("BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights"), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. The document indicates that such information is available in the attached press release (Exhibit 99.1) but does not summarize the figures within the Form 6-K cover page itself.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, contingencies, and unusual items are not detailed in the provided text. The filing references the incorporation of the Q4 and Full Year 2025 results, where such commentary would typically be found, but the content of that exhibit is absent from this input.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for Q4 and Full Year 2025 in Exhibit 99.1.
- Confirm cash position and liquidity runway as reported in the full financial results.
- Review management's operational highlights and any updates on product approvals or clinical trial results mentioned in the press release.
- Check for any new risk factors or legal contingencies disclosed in the full report.